American Journal of Advanced Drug Delivery Offener Zugang

Abstrakt

Medication Adherence in Diabetes Mellitus: An Overview on Pharmacist Role

S.Z. Inamdar, R.V. Kulkarni, S.R Karajgi, F.V.Manvi, M.S.Ganachari, B.J.Mahendra Kumar

Diabetes mellitus is chronic disease where the medication regimen contains many aspects that make compliance difficult. Whatever is the efficacy of a drug, it cannot act unless the patient takes it. Treatment may be complex, intrusive and inconvenient. Many patients are prescribed very complicated regime of diet, exercise, and medication including several pills a day. Such complexity of treatment and factors like age, duration of diseases, depression, disabilities, psychosocial issues and life style changes directly or indirectly influences diseases self management. Adherence to treatment regimen is the key link between treatment and outcome in medical care. Low medication adherence has assumed importance as it seriously undermines the benefits of current medical care and imposes a significant financial burden on individual patients and the health care system as a whole. Poor adherence to the prescribed medication regimen is a critical health care concern for the health care providers all over the world. The problem of making sure the patient follow prescriptions is as old as medicine itself. Pharmacist can contribute and play major role in the assessment of patients understanding of the illness and therapy, communicate the benefits or treatment, assess the patient’s readiness to the care plan, and discuss any barriers to adherence that patients may have. Medication adherence richly deserves attention and much impetus is needed to develop new ideas and theories to improve it. WHO has emphasized the pressing need to undertake more research in developing countries as data from developing country concerning the prevalence and treatment adherence in diabetes patients are particularly scarce.

Haftungsausschluss: Dieser Abstract wurde mit Hilfe von Künstlicher Intelligenz übersetzt und wurde noch nicht überprüft oder verifiziert